X4 Pharmaceuticals Posts Updated Corporate Presentation (Sept 8, 2026)

What Happened
X4 Pharmaceuticals, Inc. (ticker: XFOR) filed a Current Report on Form 8‑K on September 9, 2026, disclosing that it posted an updated corporate presentation on the company’s website on September 8, 2026. A copy of the presentation is filed with the 8‑K as Exhibit 99.1 and is incorporated by reference. The report was signed by CFO and Treasurer David Kirske on September 8, 2026.

Key Details

• Presentation posted on September 8, 2026 and filed as Exhibit 99.1 to the Form 8‑K.
• Investors can access the slide deck in the “Investors” section at www.x4pharma.com.
• The Form 8‑K was filed on September 9, 2026 and signed by CFO David Kirske.
• No earnings, financial results, executive changes, or other material transactions were announced in this filing.

Why It Matters
An updated corporate presentation is a way the company communicates its latest strategy, pipeline status and investor messaging; investors may review it for recent corporate updates or slides that summarize business progress. Because this 8‑K solely posts the presentation (and does not include new financial results or executive actions), investors looking for earnings or material transaction disclosures should await separate filings.